Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: Effects of preparation and neutron activation techniques

European Journal of Nuclear Medicine

Volumn 26, Issue 7, 1999, Pages 699-704

  Nijsen, J F W ^a   Zonnenberg, B A ^a   Woittiez, J R W ^b   Rook, D W ^a   Swildens Van Woudenberg, I A ^a   Van Rijk, P P ^a   Van het Schip, A D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b TNO   (Netherlands)

Author keywords

Hepatic metastases; Holmium; Irradiation parameters; Poly lactic acid microspheres; Radionuclide therapy

Indexed keywords

HOLMIUM; MICROSPHERE; POLYETHYLENE; POLYLACTIC ACID; RADIOISOTOPE;

ANIMAL TISSUE; ARTICLE; COLORECTAL CARCINOMA; LEUKOCYTE; LIVER CANCER; LIVER HOMOGENATE; LIVER METASTASIS; NONHUMAN; PLASMA; SWINE; TECHNIQUE; TIME;

BRACHYTHERAPY; DRUG DELIVERY SYSTEMS; HOLMIUM; HUMANS; LACTIC ACID; LIVER NEOPLASMS; MICROSPHERES; NEUTRON ACTIVATION ANALYSIS; POLYMERS; RADIOISOTOPES;

EID: 0345077425     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050440     Document Type: Article

References (20)

1. Cady B. Natural history of primary and secondary tumours ofthe liver. Semin Oncol 1983; 10: 127-135.
2. 90Y microspheres.Nucl Med Biol 1987; 14: 233-242.
3. Stribley KV, Gray BN, Chmiel RL, Heggie JCP, Bennett RC.Internal radiotherapy for hepatic metastases. I. The homogeneity of hepatic arterial blood flow. J Surg Res 1983; 34: 17-24.
4. Jaffe BM, Donegan WL, Watson F, Spratt JS. Factors influencing survival in patients with untreated hepatic metastases.Surg Gynecol Obst 1968; 127: 1-11.
5. Ho S, Lau WY, Leung TWT, Chan M, Ngar YK, Johnson PJ,Li AKC. Clinical evaluation of the partition model for estimating radation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med 1997; 24: 293-298.
6. Gray BN, Burton MA, Kelleher D, Klemp P, Matz L. Tolerance of the effects of yttrium-90 radiation. Int J Radiat OncolBiol Phys 1990; 18: 619-623.
7. Burton MA, Selective internal radiation therapy: distributionof radiation in the liver. Eur J Cancer Clin Oncol 1989; 25:1487-1491.
8. Ackerman NB, Lien WM, Kondi ES, Silverman NA. Theblood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and"large" tumours. Surgery 1969; 66: 1067-1072.
9. Hoefnagel CA. Radionuclide therapy revisited. Eur J NuclMed 1991; 18: 408-431.
10. Ackerman NB, Hechmer PA. The blood supply of experimental liver metastases. V. Increased tumour perfusion with epinephrine. Am J Surg 1980; 140: 625-631.
11. Ackerman NB, Lien WM, Silverman NA. The blood supply ofexperimental liver metastases. III. The effects of acute ligationof the hepatic artery or portal vein. Surgery 1972; 71: 636-641.
12. Folkman J. Tumour angiogenesis. Cancer Med 1993; 153-170.
13. Sasaki Y, Imaoka S, Hasegawa Y, Nakano S, Ishikawa O, Ohigashi H, Taniguchi K, Koyama H, Iwanaga T, Terasawa T.Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer.Cancer 1985; 55: 311-316.
14. Andrews JC, Walker-Andrews SC, Juni JA, Warber S, Ensminger WD. Modulation of liver tumour blood flow with hepaticepinephrine: a SPECT study. Radiology 1989; 173: 645-647.
15. Meade VM, Burton MA, Gray BN, Self GW. Distribution ofdifferent sized microspheres in experimental hepatic tumours.Eur J Cancer Clin Oncol 1987; 23: 37-41.
16. Anderson JH, Angerson WJ, Willmott N, Kerr DJ, McArdleCS, Cooke TG. Regional delivery of microspheres to liver metastases: the effects of particle size and concentration on intrahepatic distribution Br J Cancer 1991; 64: 1031-1034.
17. Haesegawa T, Song CW. Effect of hydralazine on the bloodflow in tumours and normal tissues in rats. Int J Radiat OncolBiol Phys 1991; 20: 1001-1007.
18. Andrews JC. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinicalfollow-up. J Nucl Med 1994; 35: 1637-1644.
19. Mumper RJ, Ryo UY, Jay M. Neutron activated holmium-166-poly (L-lactic acid) microspheres: a potential agent for the internal radiation therapy of hepatic tumours. J Nucl Med 1991;32: 2139-2143.
20. 166Ho-microsphere liver radiotherapy: apreclinical SPECT dosimetry study in the pig. Nucl Med Commun 1994; 15: 545-553.